HHC
JNCE

Hutchin Hill Capital’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Hutchin Hill Capital’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-30,100
Closed -$422K – 1012
2017
Q2 		$422K Buy
+30,100
New +$422K 0.01% 694